Ameriprise Financial Inc Adma Biologics, Inc. Transaction History

Ameriprise Financial Inc

  • $356 Billion
  • Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 673,143 shares of ADMA stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
673,143
Previous 715,672 5.94%
Holding current value
$11.9 Million
Previous $12.3 Million 8.82%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$15.44 - $20.61 $656,647 - $876,522
-42,529 Reduced 5.94%
673,143 $13.4 Million
Q4 2024

Feb 14, 2025
BUY
$15.62 - $22.62 $1.38 Million - $2 Million
88,542 Added 14.12%
715,672 $12.3 Million
Q3 2024

Nov 14, 2024
BUY
$11.21 - $20.03 $5.65 Million - $10.1 Million
504,357 Added 410.8%
627,130 $12.5 Million
Q2 2024

Aug 14, 2024
SELL
$5.98 - $11.18 $578,654 - $1.08 Million
-96,765 Reduced 44.08%
122,773 $1.37 Million
Q1 2024

May 15, 2024
SELL
$4.4 - $6.74 $567,028 - $868,583
-128,870 Reduced 36.99%
219,538 $1.45 Million
Q4 2023

Feb 14, 2024
SELL
$3.08 - $4.52 $218,470 - $320,612
-70,932 Reduced 16.92%
348,408 $1.57 Million
Q3 2023

Nov 14, 2023
BUY
$3.47 - $4.61 $57,719 - $76,682
16,634 Added 4.13%
419,340 $1.5 Million
Q2 2023

Aug 14, 2023
BUY
$3.12 - $4.22 $102,473 - $138,601
32,844 Added 8.88%
402,706 $1.49 Million
Q1 2023

May 15, 2023
SELL
$3.01 - $3.87 $1,113 - $1,431
-370 Reduced 0.1%
369,862 $1.22 Million
Q4 2022

Feb 14, 2023
SELL
$2.47 - $3.88 $9,692 - $15,225
-3,924 Reduced 1.05%
370,232 $1.44 Million
Q3 2022

Nov 14, 2022
SELL
$2.03 - $2.86 $23,176 - $32,652
-11,417 Reduced 2.96%
374,156 $910,000
Q2 2022

Aug 15, 2022
BUY
$1.43 - $2.2 $551,369 - $848,260
385,573 New
385,573 $764,000
Q1 2021

May 17, 2021
SELL
$1.67 - $2.95 $35,738 - $63,130
-21,400 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$1.8 - $2.56 $49,104 - $69,836
-27,280 Reduced 56.04%
21,400 $44,000
Q3 2020

Nov 16, 2020
BUY
$2.04 - $3.74 $4,630 - $8,489
2,270 Added 4.89%
48,680 $116,000
Q2 2020

Aug 14, 2020
BUY
$2.42 - $3.29 $34,146 - $46,421
14,110 Added 43.68%
46,410 $136,000
Q1 2020

May 15, 2020
BUY
$1.5 - $4.59 $13,050 - $39,933
8,700 Added 36.86%
32,300 $93,000
Q4 2019

Feb 14, 2020
SELL
$3.89 - $5.15 $87,155 - $115,385
-22,405 Reduced 48.7%
23,600 $94,000
Q3 2019

Nov 14, 2019
SELL
$3.19 - $5.39 $10,830 - $18,299
-3,395 Reduced 6.87%
46,005 $205,000
Q2 2019

Aug 14, 2019
BUY
$3.52 - $5.24 $173,888 - $258,856
49,400 New
49,400 $191,000

Others Institutions Holding ADMA

# of Institutions
378
Shares Held
188M
Call Options Held
2.53M
Put Options Held
696K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.46B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email